Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 8524267, 15 pages
http://dx.doi.org/10.1155/2016/8524267
Research Article

Differential Mitochondrial Adaptation in Primary Vascular Smooth Muscle Cells from a Diabetic Rat Model

1Division of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
2Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA
3Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
4Department of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
5Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
6Center for Women’s Health Research, University of Colorado School of Medicine, Aurora, CO 80045, USA

Received 18 September 2015; Revised 10 November 2015; Accepted 19 November 2015

Academic Editor: Umesh Yadav

Copyright © 2016 Amy C. Keller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. T. Bloomgarden, “Cardiovascular disease and diabetes,” Diabetes Care, vol. 26, no. 1, pp. 230–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. G. H. Gibbons and V. J. Dzau, “The emerging concept of vascular remodeling,” The New England Journal of Medicine, vol. 330, no. 20, pp. 1431–1438, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Zieman, V. Melenovsky, and D. A. Kass, “Mechanisms, pathophysiology, and therapy of arterial stiffness,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 932–943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Swärd, K. Dreja, A. Lindqvist, E. Persson, and P. Hellstrand, “Influence of mitochondrial inhibition on global and local [Ca2+]i in rat tail artery,” Circulation Research, vol. 90, no. 7, pp. 792–799, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Taggart and S. Wray, “Hypoxia and smooth muscle function: key regulatory events during metabolic stress,” Journal of Physiology, vol. 509, part 2, pp. 315–325, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. K. Salabei and B. G. Hill, “Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation,” Redox Biology, vol. 1, no. 1, pp. 542–551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Davidson, “Endothelial mitochondria and heart disease,” Cardiovascular Research, vol. 88, no. 1, pp. 58–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Mayr, Y. Hu, H. Hainaut, and Q. Xu, “Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells,” The FASEB Journal, vol. 16, no. 11, pp. 1423–1425, 2002. View at Google Scholar · View at Scopus
  9. Z. Ungvari, W. E. Sonntag, and A. Csiszar, “Mitochondria and aging in the vascular system,” Journal of Molecular Medicine, vol. 88, no. 10, pp. 1021–1027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R.-H. Zhou, A. E. Vendrov, I. Tchivilev et al., “Mitochondrial oxidative stress in aortic stiffening with age the role of smooth muscle cell function,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 745–755, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Anderson, M. E. Lustig, K. E. Boyle et al., “Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans,” Journal of Clinical Investigation, vol. 119, no. 3, pp. 573–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich, “Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species,” Physiological Reviews, vol. 89, no. 1, pp. 27–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. K. Chacko and R. Cheluvappa, “Increased ceruloplasmin and fibrinogen in type 2 diabetes corresponds to decreased anti-oxidant activity in a preliminary tertiary south Indian hospital study,” Experimental and Clinical Endocrinology & Diabetes, vol. 118, no. 1, pp. 64–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. A. Ma, Z. Zhao, and J. Turk, “Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus,” Experimental Diabetes Research, vol. 2012, Article ID 703538, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wang, A. Alexanian, R. Ying et al., “Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 712–720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. L. Archer, “Mitochondrial dynamics—mitochondrial fission and fusion in human diseases,” The New England Journal of Medicine, vol. 369, no. 23, pp. 2236–2251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Abhijit, R. Bhaskaran, A. Narayanasamy et al., “Hyperinsulinemia-induced vascular smooth muscle cell (VSMC) migration and proliferation is mediated by converging mechanisms of mitochondrial dysfunction and oxidative stress,” Molecular and Cellular Biochemistry, vol. 373, no. 1-2, pp. 95–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Shenouda, M. E. Widlansky, K. Chen et al., “Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus,” Circulation, vol. 124, no. 4, pp. 444–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Zorzano, M. Liesa, and M. Palacín, “Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 10, pp. 1846–1854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Nilsson and C. Aalkjaer, “Vasomotion: mechanisms and physiological importance,” Molecular Interventions, vol. 3, no. 2, pp. 79–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Nisoli, E. Clementi, C. Paolucci et al., “Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide,” Science, vol. 299, no. 5608, pp. 896–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Nisoli and M. O. Carruba, “Nitric oxide and mitochondrial biogenesis,” Journal of Cell Science, vol. 119, no. 14, pp. 2855–2862, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Nisoli, C. Tonello, A. Cardile et al., “Cell biology: calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS,” Science, vol. 310, no. 5746, pp. 314–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Kawashima, “The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis,” Endothelium, vol. 11, no. 2, pp. 99–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kawashima and M. Yokoyama, “Dysfunction of endothelial nitric oxide synthase and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 6, pp. 998–1005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. N. D. Roe and J. Ren, “Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases,” Vascular Pharmacology, vol. 57, no. 5-6, pp. 168–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Bitar, S. Wahid, S. Mustafa, E. Al-Saleh, G. S. Dhaunsi, and F. Al-Mulla, “Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes,” European Journal of Pharmacology, vol. 511, no. 1, pp. 53–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Laurent, M. Alivon, H. Beaussier, and P. Boutouyrie, “Aortic stiffness as a tissue biomarker for predicting future cardiovascular events in asymptomatic hypertensive subjects,” Annals of Medicine, vol. 44, supplement 1, pp. S93–S97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. W. Miller, L. A. Knaub, L. F. Olivera-Fragoso et al., “Nitric oxide regulates vascular adaptive mitochondrial dynamics,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 304, no. 12, pp. H1624–H1633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Keller, L. A. Knaub, M. W. Miller, N. Birdsey, D. J. Klemm, and J. E. B. Reusch, “Saxagliptin restores vascular mitochondrial exercise response in the Goto-Kakizaki rat,” Journal of Cardiovascular Pharmacology, vol. 65, pp. 137–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. C. V. Garat, J. T. Crossno Jr., T. M. Sullivan, J. E. B. Reusch, and D. J. Klemm, “Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 α′ catalytic subunit,” Journal of Cardiovascular Pharmacology, vol. 55, no. 5, pp. 469–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. L. A. Walker, P. Gailly, P. E. Jensen, A. V. Somlyo, and A. P. Somlyo, “The unimportance of being (protein kinase C) epsilon,” The FASEB Journal, vol. 12, no. 10, pp. 813–821, 1998. View at Google Scholar · View at Scopus
  34. G. J. Babu, G. J. Pyne, Y. Zhou et al., “Isoform switching from SM-B to SM-A myosin results in decreased contractility and altered expression of thin filament regulatory proteins,” American Journal of Physiology—Cell Physiology, vol. 287, no. 3, pp. C723–C729, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. L. Sutliff and R. J. Paul, “Smooth muscle studies using gene-altered mouse models: a users guide,” in Cardiovascular Physiology in the Genetically Engineered Mouse, B. D. Hoit and R. A. Walsh, Eds., Kluwer Academic Publishers, Boston, Mass, USA, 1998. View at Google Scholar
  36. K. E. Boyle, D. Zheng, E. J. Anderson, P. D. Neufer, and J. A. Houmard, “Mitochondrial lipid oxidation is impaired in cultured myotubes from obese humans,” International Journal of Obesity, vol. 36, no. 8, pp. 1025–1031, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. V. Kuznetsov, V. Veksler, F. N. Gellerich, V. Saks, R. Margreiter, and W. S. Kunz, “Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells,” Nature Protocols, vol. 3, no. 6, pp. 965–976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M.-H. Zou, C. Shi, and R. A. Cohen, “Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite,” The Journal of Clinical Investigation, vol. 109, no. 6, pp. 817–826, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Spinazzi, A. Casarin, V. Pertegato, M. Ermani, L. Salviati, and C. Angelini, “Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders,” Mitochondrion, vol. 11, no. 6, pp. 893–904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. D. Brand and D. G. Nicholls, “Assessing mitochondrial dysfunction in cells,” Biochemical Journal, vol. 435, no. 2, pp. 297–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Mulligan, C. H. Le, A. B. Demooy, C. B. Nelson, and A. J. Chicco, “Inhibition of delta-6 desaturase reverses cardiolipin remodeling and prevents contractile dysfunction in the aged mouse heart without altering mitochondrial respiratory function,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 69, no. 7, pp. 799–809, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. L. A. R. Group, “Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes,” The New England Journal of Medicine, vol. 369, no. 2, pp. 145–154, 2013. View at Publisher · View at Google Scholar
  43. L. Wilson, Q. Yang, J. D. Szustakowski, P. S. Gullicksen, and R. Halse, “Pyruvate induces mitochondrial biogenesis by a PGC-1 α-independent mechanism,” American Journal of Physiology—Cell Physiology, vol. 292, no. 5, pp. C1599–C1605, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Peeters, A. B. Shinde, R. Dirkx et al., “Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1α independent proliferation,” Biochimica et Biophysica Acta, vol. 1853, no. 2, pp. 285–298, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Li, R. Pan, R. Li et al., “Mitochondrial biogenesis and peroxisome proliferator-activated receptor-γ coactivator-1α(PGC-1α) deacetylation by physical activity: intact adipocytokine signaling is required,” Diabetes, vol. 60, no. 1, pp. 157–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Hulsmans, E. Van Dooren, and P. Holvoet, “Mitochondrial reactive oxygen species and risk of atherosclerosis,” Current Atherosclerosis Reports, vol. 14, no. 3, pp. 264–276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Yu, B. S. Jhun, and Y. Yoon, “High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission,” Antioxidants and Redox Signaling, vol. 14, no. 3, pp. 425–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Boudina, S. Sena, C. Sloan et al., “Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin sensitivity,” Endocrinology, vol. 153, no. 6, pp. 2677–2688, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Bugger and E. D. Abel, “Mitochondria in the diabetic heart,” Cardiovascular Research, vol. 88, no. 2, pp. 229–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. Y.-E. Cho, A. Basu, A. Dai, M. Heldak, and A. Makino, “Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice,” American Journal of Physiology—Cell Physiology, vol. 305, no. 10, pp. C1033–C1040, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. D. K. Coletta and L. J. Mandarino, “Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 301, no. 5, pp. E749–E755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Lefort, B. Glancy, B. Bowen et al., “Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle,” Diabetes, vol. 59, no. 10, pp. 2444–2452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. P. J. Oliveira, A. P. Rolo, R. Seiãça, C. M. Palmeira, M. S. Santos, and A. J. M. Moreno, “Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate,” Bioscience Reports, vol. 21, no. 1, pp. 45–53, 2001. View at Google Scholar · View at Scopus
  54. I. Pagel-Langenickel, J. Bao, L. Pang, and M. N. Sack, “The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance,” Endocrine Reviews, vol. 31, no. 1, pp. 25–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. V. B. Schrauwen-Hinderling, M. Roden, M. E. Kooi, M. K. C. Hesselink, and P. Schrauwen, “Muscular mitochondrial dysfunction and type 2 diabetes mellitus,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 6, pp. 698–703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. L. A. Knaub, S. McCune, A. J. Chicco et al., “Impaired response to exercise intervention in the vasculature in metabolic syndrome,” Diabetes and Vascular Disease Research, vol. 10, no. 3, pp. 222–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. K.-H. Chen, X. Guo, D. Ma et al., “Dysregulation of HSG triggers vascular proliferative disorders,” Nature Cell Biology, vol. 6, no. 9, pp. 872–883, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. G. R. Y. De Meyer, M. O. J. Grootaert, C. F. Michiels, A. Kurdi, D. M. Schrijvers, and W. Martinet, “Autophagy in vascular disease,” Circulation Research, vol. 116, pp. 468–479, 2015. View at Publisher · View at Google Scholar